Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
about
Expression of hepatoma-derived growth factor in hepatocarcinogenesisThe global epidemiology of hepatocellular carcinoma: present and futureDietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis modelDietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature reviewDiabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal womenHepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis CAssociation between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.Recent advances in the development of farnesoid X receptor agonistsMulticentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitisEpidemiology of primary and secondary liver cancers.Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.Promoting Effects of Streptozotocin-induced Diabetes on Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in RatsThe role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.Recent advances in the treatment of non-alcoholic fatty liver disease.Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantationPseudolymphoma of the liver: a case report and literature review.Is liver disease a threat to patients with metabolic disorders?First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease.Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinomaInvestigation of genome instability in patients with non-alcoholic steatohepatitis.Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.Management and diagnosis of fatty liver disease.V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis.Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report.Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.Body composition analysis of obesity and hepatic steatosis in mice by relaxation compensated fat fraction (RCFF) MRI.Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis.
P2860
Q28208376-40566659-9695-4E84-A1E5-80E39663DD59Q28654353-150D428A-502A-4F4E-AAE5-1026D4FBFD2BQ30301218-4CAFB817-3A34-4EB8-9B8D-4B4507CC1B0FQ30486045-AB6C5A77-8123-4F75-980A-1A93280DDE05Q33691490-F4152070-AC5F-4695-8AE5-27FFD14AF103Q33756230-7663F84A-1327-4DF4-8F04-5C1EAA9F5B95Q34055857-6F43AE10-384C-42ED-A5D4-3576CB53F2C8Q34225573-0B4325A6-A1BC-4A8F-843E-84EE419EEC2FQ34304174-9AF58F1A-3E66-40D5-A1E4-B9BFDBF00304Q34464043-F7064624-D61C-409B-982D-9E8790420CCDQ34560811-2DAC1054-8B8D-40F9-94D7-AA85DD67EB61Q34563350-08BF3C8A-F59D-4DF8-8CDF-3EC879FA1B5CQ35200808-3E592085-FB5F-445F-88DB-E4FE53A186AAQ35603922-4D221033-F96C-41A1-A03F-0CD01373EEDBQ35688212-DAE6915B-8D56-4FDE-A48B-C7BAF8957013Q36040859-BBF796CC-7283-46F0-8B3C-6242F54A0971Q36165357-AC7DE5C8-EB12-4919-A8AD-7E179C74FE54Q36171486-8C24FC05-652B-4BEC-B0E1-5143E2CCE35DQ36265230-F2D75086-00EA-4623-BE80-44B0EA0F1C3FQ36501848-D79EE775-C838-4271-ACA7-E51AE20CFCE3Q37031706-BD11F443-5A4F-4362-B5AF-3809BC672DE1Q37118838-CDF834B0-2E7E-4302-BD2E-72DFF42AE2F5Q37503151-16B5F5C1-5ECA-4A6A-88FC-ECAC807800A9Q37932057-D51F02DC-5955-4CAD-AC5C-F33DD136B0B2Q38164076-A32AE040-E674-4E9C-B3DE-8B15AE0824AAQ38365276-C994948F-315D-4295-9FA8-53333864D621Q39407448-F04C10ED-8865-4483-9C70-73B27C23F6AEQ40207862-8F625ABF-5F48-404F-8A1E-0ABB4AC56A29Q40707598-769BFD6F-3B08-4055-89B0-219080F6B5CFQ42633257-CF119334-2C76-4C28-A70F-2EFB571AE522Q43826988-FE9C2AE2-1456-43EF-821C-BB2B249E74DDQ44080642-CE11C25A-5FF2-4C77-A16D-A80364920082Q46654267-8071CC73-EB32-4D73-B04B-EDE2A63B5744Q51347740-BA7A2BFD-2921-45EE-8B14-E06B610B8A76Q51488549-344CF91C-7488-40C2-A999-13428228741DQ51665999-AF75318E-0FD2-4CAC-AEDE-532A020F94DBQ51747614-63AF34B0-BC31-4508-B7C5-BCAAA484BEFE
P2860
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@ast
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@en
type
label
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@ast
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@en
prefLabel
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@ast
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@en
P2093
P2860
P1476
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
@en
P2093
P2860
P304
P356
10.1046/J.1440-1827.2001.01174.X
P577
2001-02-01T00:00:00Z